eTable 2.
Trial, Year | Did the study attempt to enroll a random sample or consecutive patients meeting inclusion criteria (inception cohort)? | Were the groups comparable at baseline? | Did the study use accurate methods for ascertaining exposures, potential confounders, and outcomes? | Were outcome assessors and/or data analysts blinded to treatment? | Did the article report attrition? | Did the study perform appropriate statistical analyses on potential confounders? | Is there important differential loss to follow-up or overall high loss to follow-up? | Were outcomes pre-specified and defined, and ascertained using accurate methods? | Quality |
---|---|---|---|---|---|---|---|---|---|
| |||||||||
NELSON, 200816 | Yes | NR | Yes | No | Yes | No | No | Yes | Fair |
NELSON, 201017 | Yes | Yes | Yes | No | Yes | Yes | NR | Yes | Fair |
PLuSS, 200819 | Yes | No | Yes | No | Yes | Yes | No | Yes | Fair |
Abbreviations: DLCST = Danish Lung Cancer Screening Trial; LDCT = low-dose computed tomography; NELSON = Nederlands-Leuvens Longkanker Screenings Onderzoek; NR = Not reported; PLuSS = Pittsburgh Lung Screening Study